SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Shorting stocks: Broken stocks - Analysis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dale Baker who wrote (1912)10/15/1998 4:44:00 AM
From: Q.  Read Replies (1) of 2506
 
re. a target for MCAR:

It's a development stage co., where the product they are attempting to license is merely a proprietary unpatented treatment method for urinary incontinence.

Here's what the latest prospectus says:

The Company relies on an unpatented proprietary treatment protocol and there can be no assurances that others may not independently develop the same or similar program or otherwise obtain access to the Company's unpatented proprietary protocols.

Looking at the financials, there isn't much to the co. other than just hope that doctors will license their treatment method:

They have $0.50 / sh cash, which they are burning at $0.12/sh per year.

The revenues are almost zero: just $0.08 per share, vs. $0.27/sh General and Admin expenses. So of course they lose money.

There have never been any R&D expenses, so I'm not sure what value their product might have. If it doesn't have any value, then the stock is worth at most the cash level of $0.50.

Given the recent turmoil in the board, I'd guess there's not a lot of good news coming around the pike regarding adoption of the product. So maybe their isn't much value to what they are doing.

So I'm inclined to be patient with this one, and set an interim target of $1 or so.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News